Quilter PLC Moderna, Inc. Transaction History

Quilter PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$69.51 - $104.43 $12,233 - $18,379	-176 Reduced 30.56%	400 $39,000
Q3 2023 Nov 01, 2023	SELL	$96.41 - $126.61 $2,313 - $3,038	-24 Reduced 4.0%	576 $59,000
Q1 2023 May 16, 2023	BUY	$135.66 - $197.02 $81,396 - $118,212	600 New	600 $92,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $398,346 - $650,051	-1,764 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$221.9 - $484.47 $252,078 - $550,357	-1,136 Reduced 39.17%	1,764 $679,000
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $1.64 Million - $2.96 Million	-12,618 Reduced 81.31%	2,900 $681,000
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $1.03 Million - $1.76 Million	9,473 Added 156.71%	15,518 $2.03 Million
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $264,209 - $682,667	-4,019 Reduced 39.93%	6,045 $632,000
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $101,398 - $176,990	1,866 Added 22.76%	10,064 $712,000
Q2 2020 Aug 12, 2020	SELL	$29.67 - $80.0 $50,587 - $136,400	-1,705 Reduced 17.22%	8,198 $526,000
Q1 2020 May 08, 2020	BUY	$17.78 - $31.58 $176,075 - $312,736	9,903 New	9,903 $297,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Quilter PLC, based on Form 13F filings with the SEC.

Stay updated on Quilter PLC with notifications on news.